Cancer Family
Benign Epithelial Neoplasm
CI-CAN-00000077Explore in graph →
Non-malignant30 active trials
- NCIt
- C4092
Loading cancer entity…
Cancer Family
CI-CAN-00000077Explore in graph →
Clinical trials
161 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07301424 | Subcutaneous Blinatumomab Plus Ponatinib for BCR-ABL+ B-ALL | not yet recruiting | Phase 2 | 80 | University of AlbertaOTHER | 1 | Aug 12, 2026 | clinicaltrials |
Data updated 22 days agoSource updated Aug 12, 2026source: clinicaltrials